Affinity-independent memory B cell origin of the early antibody-secreting cell response in naive individuals upon SARS-CoV-2 vaccination.

SARS-CoV-2 affinity maturation germinal center humoral immunity mRNA vaccination pre-existing memory B cells somatic hypermutation

Journal

Immunity
ISSN: 1097-4180
Titre abrégé: Immunity
Pays: United States
ID NLM: 9432918

Informations de publication

Date de publication:
13 Aug 2024
Historique:
received: 18 12 2023
revised: 02 02 2024
accepted: 24 07 2024
medline: 22 8 2024
pubmed: 22 8 2024
entrez: 21 8 2024
Statut: aheadofprint

Résumé

Memory B cells (MBCs) formed over the individual's lifetime constitute nearly half of the circulating B cell repertoire in humans. These pre-existing MBCs dominate recall responses to their cognate antigens, but how they respond to recognition of novel antigens is not well understood. Here, we tracked the origin and followed the differentiation paths of MBCs in the early anti-spike (S) response to mRNA vaccination in SARS-CoV-2-naive individuals on single-cell and monoclonal antibody levels. Pre-existing, highly mutated MBCs showed no signs of germinal center re-entry and rapidly developed into mature antibody-secreting cells (ASCs). By contrast, and despite similar levels of S reactivity, naive B cells showed strong signs of antibody affinity maturation before differentiating into MBCs and ASCs. Thus, pre-existing human MBCs differentiate into ASCs in response to novel antigens, but the quality of the humoral and cellular anti-S response improved through the clonal selection and affinity maturation of naive precursors.

Identifiants

pubmed: 39168129
pii: S1074-7613(24)00372-8
doi: 10.1016/j.immuni.2024.07.023
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Auteurs

Zhe Li (Z)

B Cell Immunology, German Cancer Research Center, Heidelberg 69120, Germany.

Anna Obraztsova (A)

B Cell Immunology, German Cancer Research Center, Heidelberg 69120, Germany; Faculty of Biosciences, University of Heidelberg, Heidelberg 69120, Germany. Electronic address: a.obraztsova@dkfz.de.

Fuwei Shang (F)

Cellular Immunology, German Cancer Research Center, Heidelberg 69120, Germany; Faculty of Medicine, University of Heidelberg, Heidelberg 69120, Germany.

Opeyemi Ernest Oludada (OE)

B Cell Immunology, German Cancer Research Center, Heidelberg 69120, Germany; Faculty of Biosciences, University of Heidelberg, Heidelberg 69120, Germany.

Joshua Malapit (J)

B Cell Immunology, German Cancer Research Center, Heidelberg 69120, Germany; Faculty of Biosciences, University of Heidelberg, Heidelberg 69120, Germany.

Katrin Busch (K)

Cellular Immunology, German Cancer Research Center, Heidelberg 69120, Germany.

Monique van Straaten (M)

Structural Biology of Infection and Immunity, German Cancer Research Center, Heidelberg 69120, Germany.

Erec Stebbins (E)

Structural Biology of Infection and Immunity, German Cancer Research Center, Heidelberg 69120, Germany.

Rajagopal Murugan (R)

B Cell Immunology, German Cancer Research Center, Heidelberg 69120, Germany.

Hedda Wardemann (H)

B Cell Immunology, German Cancer Research Center, Heidelberg 69120, Germany. Electronic address: h.wardemann@dkfz.de.

Classifications MeSH